TY - JOUR AB - Intermitting fasting has been proposed as a dietary strategy to improve general health indicators, slow or reverse disease processes and aging. However, data supporting the beneficial health effects of intermittent fasting mainly derive from preclinical studies in animals and short-term clinical studies on weight loss and non-communicable disease risk factors, with no significant differences on these outcomes when intermittent fasting has been compared with moderate continuous energy restriction in humans. No data are available on the effect of intermitting fasting on clinically important outcomes in humans, such as the onset of cardiovascular diseases, cancer, and life expectancy. Instead, several studies found an association between delayed eating (i.e., spending many hours during the day without eating) and increased risk of developing episodes of overeating and binge eating. Moreover, the procedure of regular eating, adopted by the “enhanced” cognitive behavior therapy for eating disorders (CBT-E), results in a rapid decease in the frequency of binge-episodes in patients with bulimia nervosa and binge-eating disorders. These data indicate that regular eating, not intermitting fast, is the best choice for adopting a healthy eating control and avoiding the development of unregulated and, in some cases, disturbed eating behavior. AU - Dale Grave, R. DA - 2020/02/12 DO - 10.32044/ijedo.2020.02 KW - Intermittent fasting Regular eating Starvation Life expectancy Health disease Aging Eating disorders Bulimia nervosa Binge-eating disorder M3 - Original article PY - 2020 SN - 2612-6354 SP - 5-7 ST - Regular eating, not intermittent fasting, is the best strategy for a healthy eating control T2 - IJEDO TI - Regular eating, not intermittent fasting, is the best strategy for a healthy eating control UR - https://www.doi.org/10.32044/ijedo.2020.02 VL - 2 ID - 2491 ER - TY - JOUR AB - Objective: This study aimed to conduct a systematic review on the effects of available treatments for avoidant/restrictive food intake disorder (ARFID). Methods: Literature searches, study selection, method development, and quality appraisal were performed independently by one author, and data were synthesized using a narrative approach. Studies published in English and in peer-reviewed journals that evaluated the outcomes of ARFID treatments in at least three participants were taken into consideration, while non-original studies, editorials and letters to the editor were excluded. Results: The review had three main findings. First, in all of the studies by the end of the treatment there was a significant weight gain in the ARFID participants. Second, weight recovery was maintained at follow-up in a good percentage of participants with an associated improvement of eating behavior and a reduction in anxiety, depression, and fear for the adverse consequences of eating. Third, there was weak or missing evidence regarding the treatment of ARFID in adults and the difference in outcome in the three different ARFID profiles. Eighteen studies were selected and eleven were included. Conclusion: The treatments for ARFID, although promising, have focused only on young participants and addressed the normalization of eating with behavioral procedures, but not the underlying psychopathology. Moreover, the lack of randomized controlled trials with adequate statistical power does not allow to draw conclusions on the difference in the effectiveness of the interventions tested. AU - Dalle Grave, A. AU - Sapuppo, W. DA - 2020/05/15 DO - 10.32044/ijedo.2020.04 KW - Avoidant/restrictive food intake disorder Treatment Cognitive behavior therapy Family-based treatment Eating and feeding disorders L1 - internal-pdf://3829176297/ijedo-202004.pdf M3 - Original article PY - 2020 SN - 2612-6354 SP - 13-23 ST - Treatment of avoidant/restrictive food intake disorder: a systematic review T2 - IJEDO TI - Treatment of avoidant/restrictive food intake disorder: a systematic review UR - https://onlineijedo.positivepress.net/articoli/ijedo202004 VL - 2 ID - 2522 ER - TY - JOUR AB - The concept of food addiction has attracted a growing interest in the media and has stimulated many debates in the scientific community. The aim of this article is to analyze the validity and clinical utility of the food addiction model applied to eating disorders and obesity, in particular. Although there are some similarities between the binge-eating episodes of reported by people with eating disorders and substance use disorder, there are fundamental differences between the two disorders concerning the psychopathology, epidemiology and risk factors. In people with obesity, although some studies have reported common brain reward processes between the intake of certain foods and the use of addictive substances, this does not mean that a food capable of activating the reward system can be classified as an addictive. Indeed, the overeating reported by some people with obesity may be explained through the acquisition of habits determined by the activation of normal hedonic processes (not pathological), in a food environment that is dense of energy and culturally permissive. Furthermore, there are important differences between obesity and substance use disorder, such as the time course of relapse and treatment outcomes. Finally, the adoption of a treatment based on the model of food addiction in eating disorders and obesity is a source of concern because it could move away the people suffering from these disorders from therapies of proven efficacy. AU - Dalle Grave, Riccardo DA - 2019/04/20 DO - 10.32044/ijedo.2019.05 KW - Food addiction Obesity Eating disorders Treatment Cognitive behavior therapy M3 - Original article PY - 2019 SN - 2612-6354 SP - 34-41 ST - Food addiction: un concetto di scarsa validità e utilità clinica T2 - IJEDO TI - Food addiction: un concetto di scarsa validità e utilità clinica UR - https://www.doi.org/10.32044/ijedo.2019.05 VL - 1 ID - 2439 ER - TY - JOUR AU - Dalle Grave, Riccardo AU - Banderali, Arianna AU - Campagna, Sara AU - Camporese, Lucia AU - Filardo, Domenico AU - Iarrera, Francesco AU - Massa, Marco AU - Sartirana, Massimiliano AU - Sermattei, Selvaggia AU - Bacchetta, Monica AU - Calugi, Simona DA - 2019/03/27 DO - 10.32044/ijedo.2019.04 L1 - internal-pdf://1101513921/ijedo-2019-04.pdf M3 - Position paper PY - 2019 SN - 2612-6354 SP - 29-33 ST - Position Paper – AIDAP: Evidence-based psychological treatments and not multidisciplinary eclectic treatments as first approach of eating disorders T2 - IJEDO TI - Position Paper – AIDAP: Evidence-based psychological treatments and not multidisciplinary eclectic treatments as first approach of eating disorders UR - https://www.doi.org/10.32044/ijedo.2019.04 VL - 1 ID - 2438 ER - TY - JOUR AB - Binge-eating disorder (BED) is characterized by the presence of recurrent binge-eating episodes not followed by the recurrent use of compensatory behaviors, occurring at least once a week for three months, and associated with marked distress. According to the most recent data, BED has a lifetime prevalence of 0.85% (men 0.42% and women 1.25%). The disorder, although it is also present in normal-weight individuals, is more frequent in those with obesity. BED often coexists with specific mental disorders (e.g., depressive disorders, anxiety disorders, substance use disorders, or impulse control disorders) and with general medical conditions (e.g., cardiometabolic diseases). Psychological treatments, such as cognitive behaviour therapy (CBT), produce remission of binge-eating episodes in about 50-55% of patients, but have a limited effect on weight loss when BED is associated with obesity. Pharmacological treatments for anxiety and depression have limited effects on the symptoms of BED, while some drugs that have shown promising results, such as lisdexamfetamine and dasotraline, are often burdened with important side effects and are not available in Italy. The need to develop a treatment able to determine both a modest, but clinically significant, weight loss and a simultaneous remission of binge-eating episodes and associated psychopathology, has led to design a new treatment, under evaluation, called “CBT-BO”, which integrates strategies and procedures of the CBT-E for eating disorders and CBT for obesity. AU - Dalle Grave, R. AU - Sartirana, M. AU - Calugi, S. DA - 2020/10/01 DO - 10.32044/ijedo.2020.06 KW - Binge-eating disorder Obesity Comorbidity Epidemiology Treatment Cognitive behaviour therapy L1 - internal-pdf://0719885339/ijedo202006.pdf M3 - Original article PY - 2020 SE - 29 SN - 2612-6354 SP - 29-40 ST - Disturbo da binge-eating – Un update T2 - IJEDO TI - Disturbo da binge-eating – Un update UR - https://www.doi.org/10.32044/ijedo.2020.06 VL - 2 ID - 2524 ER - TY - JOUR AB - Introduction. The study of the changes occurring during psychological interventions is one of the main challenges faced by clinical researchers in the last years. This is why accurate tools are needed to capture rapid changes. The aim of this study is to present the validation of the Eating Problem Checklist (EPCL), a questionnaire developed in Italy to be administered session by session to assess the behaviors and psychopathology of eating disorders. Methods. A sample of 161 subjects with eating disorder and a sample of 379 healthy controls completed the EPCL. In addition, a subset of 75 patients completed it at each enhanced cognitive behavioral therapy (CBT-E) session. Results. The analysis of the main components identified two factors (“body image concerns” and “eating concerns”) explaining, on the whole, 51.3% of the variance. The internal consistency, test-retest reliability, concurrent and criterion validity were good. Furthermore, the EPCL was found to be adequate to identify post-session changes of the eating disorder psychopathology, in subjects who received it during CBT-E. Discussion: The EPCL proved to be a valid and reliable questionnaire. Its use in the clinical context can give relevant information on the weekly change in psychopathology and behaviors of patients with eating disorders. AU - Dalle Grave, R. AU - Sermattei, S. AU - Calugi, S. DA - 2019/02/22 DO - 10.32044/ijedo.2019.03 KW - Session Eating disorders Questionnaire Validation Reliability Principal component analysis M3 - Original article PY - 2019 SN - 2612-6354 SP - 17-28 ST - Proprietà psicometriche del questionario in lingua italiana Eating Problem Checklist somministrato ad un campione di soggetti con disturbo dell’alimentazione T2 - IJEDO TI - Proprietà psicometriche del questionario in lingua italiana Eating Problem Checklist somministrato ad un campione di soggetti con disturbo dell’alimentazione UR - https://www.doi.org/10.32044/ijedo.2019.03 VL - 1 ID - 2437 ER - TY - JOUR AB - The pandemic spread of coronavirus disease (COVID-19) has forced most governments around the world to put their country on lockdown. During the lockdown, the rules on social distancing, quarantine, and isolation made the delivery of psychological therapies very complicated at all levels of care. In our Intensive Nutritional Rehabilitation Unit of Villa del Principe (Genoa - Italy) the use of remote therapy solutions to deliver enhanced cognitive behavior therapy (CBT-E) was a forced choice to guarantee the continuity of care for patients with eating disorders. CBT-E, even in its intensive form applied to inpatients, has proved particularly suitable to be delivered remotely in some of its parts. This paper examines the CBT-E procedures (for inpatients) that have undergone the greatest impact from the anti-COVID-19 measures and how these difficulties have been overcome through the use of remote solutions. AU - Massa, M. DA - 2020/05/19 DO - 10.32044/ijedo.2020.05 KW - Eating disorders Cognitive behaviour therapy CBT-E Distance therapy Telehealth Coronavirus COVID-19 L1 - internal-pdf://3829176296/ijedo202005.pdf M3 - Original article PY - 2020 SN - 2612-6354 SP - 24-28 ST - LA CBT-E a distanza nei programmi di riabilitazione residenziale intensiva per i disturbi dell’alimentazione durante l’epidemia COVID-19 T2 - IJEDO TI - LA CBT-E a distanza nei programmi di riabilitazione residenziale intensiva per i disturbi dell’alimentazione durante l’epidemia COVID-19 VL - 2 ID - 2523 ER -